Endocrinol Metab. 2007;92:2312-17.
4. Vanderpump MPJ, Tunbridge WMG, French JM, Appleton D, Bates D, Clark F, et al. The incidence of thyroid disorders in the community: a twenty year follow-up of the Wickham survey. Clin Endocrinol. 1995;43:55-68
5. Zois C, Stavrou I, Kalogera C, Svarna E. High prevalence of autoimmune thyroiditis in school children after elimination of iodinedeficiency in northwestern Greece. Thyroid. 2003; 13:485-9.
6. Inoue M, Taketani N, Sato T, Nakajima H. High incidence of chronic lymphocytic
Sonia L. Elsharkawy, Wafaa E. AbdEl-Aal, Reham S. E. Esmal, Hanan H. M. Ali, Soheir M. Mahfouz and Ahmed El-Habashi
Classification of Tumors: pathology and Genetics of Tumors of Endocrine Organs. Lyon, IARC Press, 2007.
17. Danque POV, Chen HB, Patil J, et al. Image analysis versus flow cytometry for DNA ploidy quantitation of solid tumors: a comparison of six methods of sample preparation. Mod Pathol. 1993; 6:270-275.
18. Onaran Y, Tezelman S, Gurel N, Teiziolgu T, Oguz H, Tanakol R, KapranY. The value of DNA content in predicting the prognosis of thyroid carcinoma in an iodinedeficiency region. Acta chir belg. 1999;99:30-35.
19. Borget I, Vielh P, Leboulleux S, Allyn M, De
Rucsandra Dănciulescu Miulescu and Andrada Doina Mihai
. Romano R, Jannini EA, Pepe M et al. The effects of iodoprophylaxis on thyroid size during pregnancy. Am J Obstet Gynecol 164: 482-485, 1991.
10. World Health Organization. United Nations Children’s Fund & International Council for the Control of IodineDeficiency Disorders. Assessment of iodinedeficiency disorders and monitoring their elimination, 3rd ed. Geneva, Switzerland: WHO, 2007. Accessed at: www.who.int/nutrition/publications/WHOStatement__IDD_pregnancy.
11. Yoshimura M, Hershman JM. Thyrotropic action of human chorionic